Enteral Access Technologies vs NeuroPace
Enteral Access Technologies vs NeuroPace, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enteral Access Technologies is on 38/100 and NeuroPace on 67/100.
Where each one leads
Enteral Access Technologies
Leads on none of the measures we hold for both companies.
NeuroPace
- our overall score: 67/100 against 38/100
- agent readiness: 47/100 against 22/100
- funding raised: $475M against $3.1M
At a glance
| Measure | Enteral Access Technologies | NeuroPace |
|---|---|---|
| What it is | Develops innovative solutions for improved enteral feeding access and delivery. | Develops a brain-computer interface for treating epilepsy. |
| Category | MedTech, HealthTech, Medical Devices, Patient Care | MedTech, HealthTech, Brain-Computer Interface, Non-Invasive BCI |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Hardware |
| Founded | 2017 | 1997 |
| Headquarters | San Diego, United States | Mountain View, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Enteral Access Technologies | NeuroPace |
|---|---|---|
| Employees | Not published | 248 |
| Total funding | $3.1M | $475M |
| Latest round | Seed | IPO |
| Valuation | Not published | $375M |
| LinkedIn followers | Not published | 32,261 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enteral Access Technologies | NeuroPace |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 38/100 | 67/100 |
| Traction | 32/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Community | 13/100 | Not published |
| Search visibility | 10/100 | 35/100 |
| Quality | 45/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | Not published | 52/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enteral Access Technologies | NeuroPace |
|---|---|---|
| Hosting | Not detected | AWS |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager, Hotjar |
Enteral Access Technologies vs NeuroPace: common questions
Which is better, Enteral Access Technologies or NeuroPace?
On our 0-100 score NeuroPace rates higher (67/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Enteral Access Technologies and NeuroPace compare on the numbers?
NeuroPace leads on our overall score (67/100 against 38/100), agent readiness (47/100 against 22/100), funding raised ($475M against $3.1M).
Read the full Enteral Access Technologies review and pricing or the NeuroPace review and pricing. You can also browse other Enteral Access Technologies alternatives we track.